# Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD Relapse

> **NCT05211804** · — · COMPLETED · sponsor: **Sorlandet Hospital HF** · enrollment: 31 (actual)

## Conditions studied

- Wet Macular Degeneration

## Interventions

- **DRUG:** Ophthalmic Drugs

## Key facts

- **NCT ID:** NCT05211804
- **Lead sponsor:** Sorlandet Hospital HF
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-08
- **Primary completion:** 2024-05-21
- **Final completion:** 2024-05-21
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05211804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05211804, "Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD Relapse". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05211804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*